Breaking News
”Blood Transfusion in Thalassaemia”: Save the Date for the Next TIF Webinar for Medical Specialists
TIF Publishes its Annual Report for 2019
Viral Hepatitis & Thalassaemia: Q&A with Prof. John Koskinas
Novartis sickle cell drug Adakveo put on path to EU approval
”Liver Disease & Thalassaemia”: En route to the 3rd TIF Webinar for Medical Specialists
WORLD HEPATITIS DAY 2020: Towards a ”Hepatitis-free Future”
THOUGHTS ABOUT ME AND MY DAUGHTER by Melissa Basberber
Oxford vaccine: Early Trials Show Promising Results that Suggest “Double Protection” from Coronavirus
TIF.ACCESS: A Global TIF Initiative for the Promotion of the Availability & Accessibility of Innovative Therapies
Early-Stage Trial Data on Oxford University COVID-19 Vaccine to be Published July 20
English
Ελληνικά
Français
Deutsch
Italiano
العربية
Menu
Home
Who we are
TIF History
Vision & Mission
Pillars of Work
Board of Directors
Staff Members
TIF Members
Collaborations
Transparency
Awards & Honours
What we do
Education
Country work
Projects
Haemoglobin Disorders
Thalassaemia
Sickle Cell Disease
Clinical Trial Updates
Positions & Policies
Policy Framework
Position Papers
Official Statements
Publications
TIF Publications
Scientific Literature
Additional Resources
Media Centre
News
Newsletters
Events
Videos
Contact us
Search for
RSS
Instagram
YouTube
Twitter
Facebook
Home
/
What we do
What we do
Back to top button
Close
Search for
Close
Log In
Forget?
Remember me
Log In
Cookies
This site uses cookies.
Find out more
Okay, thanks
